Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. User Boards ›
  4. Cheeky's Board! Message Board

ww.ddnotesmaker.com/OMER ##### recent news/filing

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 94264
Posted On: 11/25/2013 6:38:01 PM
Avatar
Posted By: Emylers
ww.ddnotesmaker.com/OMER

##### recent news/filings ~ source: finance.yahoo.com

Thu, 21 Nov 2013 21:10:03 GMT ~ Data on Omeros' Omidria
read full: http://finance.yahoo.com/news/data-omeros-omi...03284.html
*********************************************************

Wed, 20 Nov 2013 13:37:01 GMT ~ Omeros Announces FDA Acceptance of Omidria™ as Proprietary Name for OMS302
- SEATTLE, Nov. 20, 2013 /PRNewswire/ -- Omeros Corporation (NASDAQ: OMER) today reported that the U.S. Food and Drug Administration (FDA) accepted the proposed brand name Omidria™ for OMS302, the Company's ...
read full: http://www.noodls.com/view/40F92E7E46AA76B8F7...F8F72C9E0F
*********************************************************

Wed, 20 Nov 2013 12:07:24 GMT ~ Omeros' Omidria brand name for OMS302 accepted by FDA
read full: http://finance.yahoo.com/news/omeros-omidria-...24188.html
*********************************************************

Wed, 20 Nov 2013 12:00:00 GMT ~ Omeros Announces FDA Acceptance of Omidria™ as Proprietary Name for OMS302
- SEATTLE, Nov. 20, 2013 /PRNewswire/ -- Omeros Corporation (OMER) today reported that the U.S. Food and Drug Administration (FDA) accepted the proposed brand name Omidria™ for OMS302, the Company's proprietary product in development for use in intraoperative lens replacement (ILR) surgery. FDA's acceptance of the proprietary brand name is subject to the Agency's final determination prior to any approval of the product's New Drug Application (NDA) and market launch, expected in 2014. Omeros earlier received allowance of the trademark application for Omidria from the U.S. Patent and Trademark Office. The FDA reviews proposed proprietary names, taking into account potential for confusion between the proposed name and the names of marketed drugs and pending products for which marketing applications are currently under review.
read full: http://finance.yahoo.com/news/omeros-announce...00006.html
*********************************************************

Tue, 19 Nov 2013 14:08:20 GMT ~ Omeros up premarket on new eye surgery drug data
read full: http://sg.finance.yahoo.com/news/omeros-prema...nance.html
*********************************************************

##### chart ~ source: stockcharts.com

stockcharts.com/c-sc/sc?s=OMER&p=D&b=5&g=0&id=p95448242713

##### chart ~ source: eoddata.com

http://chart.eoddata.com/?e=OTCBB&s=OMER&...D&b=BB

##### company info ~ source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/OMER/company-info
Ticker: $OMER
OTC Market Place: Not Available
CIK code: not found
Company name: Omeros Corp.
Incorporated In:

##### extra dd links

Latest filings: http://www.otcmarkets.com/stock/OMER/filings
Latest financials: http://www.otcmarkets.com/stock/OMER/financials
Latest news: http://www.otcmarkets.com/stock/OMER/news - http://finance.yahoo.com/q/h?s=OMER+Headlines

Major holdings: http://data.cnbc.com/quotes/OMER/tab/8.1
Insider transactions (1): http://finance.yahoo.com/q/it?s=OMER+Insider+Transactions
Insider transactions (2): http://www.secform4.com/insider-trading/OMER.htm
Insider transactions (3): http://www.insidercow.com/history/company.jsp?company=OMER

RegSho: http://www.regsho.com/tools/symbol_stats.php?...rch=search

DTCC: http://search2.dtcc.com/?q=Omeros+Corp.&x...ISO-8859-1
Spoke company information: http://www.spoke.com/search?utf8=%E2%9C%93&q=Omeros+Corp.
Corporation WIKI: http://www.corporationwiki.com/search/results...=0&y=0

http://www.pennystocktweets.com/stocks/profile/OMER

##### last known share structure ~ source: otcmarkets.com

Market Value: Not Available
Shares Outstanding: Not Available
Float: Not Available
Authorized Shares: Not Available
Par Value: No Par Value

##### business description ~ source: otcmarkets.com



DD Notes ~ http://www.ddnotesmaker.com/OMER

$OMER Up to date company activities and other important information about $OMER

$OMER

DD Notes ~ http://w


(0)
(0)








Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us